Doublet Chemotherapy, Triplet Chemotherapy, or Doublet Chemotherapy Plus Radiotherapy as a Neoadjuvant Treatment for Locally Advanced Oesophageal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
Lancet 2024 Jun 11;[EPub Ahead of Print], K Kato, R Machida, Y Ito, H Daiko, S Ozawa, T Ogata, H Hara, T Kojima, T Abe, T Bamba, M Watanabe, H Kawakubo, Y Shibuya, Y Tsubosa, N Takegawa, T Kajiwara, H Baba, M Ueno, H Takeuchi, K Nakamura, Y KitagawaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.